AEON Stock Summary and Trading Ideas (Aeon Biopharma Class A | AMEX:AEON)

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

Aeon Biopharma Class A trades on the AMEX stock market under the symbol AEON.

As of June 16, 2026, AEON stock price climbed to $0.70 with 10,128 million shares trading.

AEON has a beta of -0.38, meaning it tends to be less sensitive to market movements. AEON has a correlation of 0.00 to the broad based SPY ETF.

AEON has a market cap of $18.42 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that AEON belongs to (by Net Assets): VXF.

AEON has underperformed the market in the last year with a price return of -23.2% while the SPY ETF gained +27.2%. AEON has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -36.9% and -6.7%, respectively, while the SPY returned +13.8% and -0.9%, respectively.

AEON support price is $.63 and resistance is $.70 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AEON shares will trade within this expected range on the day.